These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15202774)

  • 1. EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.
    Rojas P; Rojas C; Ebadi M; Montes S; Monroy-Noyola A; Serrano-García N
    Neurochem Res; 2004 Jul; 29(7):1417-23. PubMed ID: 15202774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGb761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum.
    Rojas P; Garduño B; Rojas C; Vigueras RM; Rojas-Castañeda J; Rios C; Serrano-Garcia N
    Neurochem Res; 2001 Nov; 26(11):1245-51. PubMed ID: 11874207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of EGb761 supplementation on the content of copper in mouse brain in an animal model of Parkinson's disease.
    Rojas P; Montes S; Serrano-García N; Rojas-Castañeda J
    Nutrition; 2009 Apr; 25(4):482-5. PubMed ID: 19091511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y; Weinstock M; Youdim MB
    J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxytyrosol inhibits MAO isoforms and prevents neurotoxicity inducible by MPP+ invivo.
    Perez-Barron GA; Montes S; Rubio-Osornio M; Avila-Acevedo JG; Garcia-Jimenez S; Rios LC; Monroy-Noyola A
    Front Biosci (Schol Ed); 2020 Jan; 12(1):25-37. PubMed ID: 31585863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
    Ozaki N; Nakahara D; Kaneda N; Kiuchi K; Okada T; Kasahara Y; Nagatsu T
    J Neural Transm; 1987; 70(3-4):241-50. PubMed ID: 3500274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
    Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
    J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B.
    Quinn LP; Crook B; Hows ME; Vidgeon-Hart M; Chapman H; Upton N; Medhurst AD; Virley DJ
    Br J Pharmacol; 2008 May; 154(1):226-33. PubMed ID: 18332857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
    Samantaray S; Mohanakumar KP
    Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM; Chen RC; Chiueh CC
    Ann N Y Acad Sci; 2000; 899():255-61. PubMed ID: 10863544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum.
    Vizuete ML; Steffen V; Ayala A; Cano J; Machado A
    Neurosci Lett; 1993 Apr; 152(1-2):113-6. PubMed ID: 8515861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.